Norgen Biotek Corp. Achieves ISO 13485:2003 and ISO 9001:2008 Certification
Norgen Biotek Corp. announced successful certification to ISO 13485:2003 and ISO 9001:2008. ISO 13485 and ISO 9001 are world-recognized quality management system standards, with ISO 13485 specifically pertaining to the requirements for a comprehensive management system for the design and manufacture of medical devices. The quality system was audited by BSI Management Systems Inc, one of the foremost auditing bodies in the world.
“We are dedicated to providing our customers with first class sample preparation kits for RNA, microRNA, DNA and protein purification, clean-up and concentration and to provide dedicated and expert support services to our customers and partners worldwide” said Dr. Yousef Haj-Ahmad, President & CEO. “And now with the ISO certification we can transition our first in class kits into diagnostics. The sensitivity and specificity of the diagnostic kit is highly dependent on sample preparation, therefore we are in an excellent position to make this successful transition” said Dr. Yousef Haj-Ahmad, President & CEO of Norgen Biotek.
Most read news
Other news from the department politics & laws

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Last viewed contents

Power-to-vitamins: microbes produce folate from simple basic ingredients - Biotechnology team obtains valuable byproduct in protein produc-tion
BioVisioN receives research grant within BioChancePLUS program
Prellis Biologics achieves milestone in 3D printing of human tissue with capillaries
Thermo Fisher Scientific and Intrinsic Bioprobes Announce Alliance in Mass Spectrometric Immunoassay (MSIA) Workflow Development

Acetylation: a Time-Keeper of glucocorticoid Sensitivity - Understanding the regulatory mechanism paves the way to enhance the effectiveness of anti-inflammatory therapies

Certain immune cells have different jobs depending on the organ
